The IT @ Networking Awards 2010

The goal of the IT @ Networking Awards 2010 (IT @ 2010), is to honour and promote outstanding healthcare IT solutions. The core aim of IT @ 2010 is to learn from the achievements of the very best IT installations on the globe.

Healthcare systems face unprecedented challenges: high-tech, high-cost medicine; ageing populations; increased patient mobility; staff shortages; and a financial crisis. Intelligent IT solutions increase cost-effectiveness, productivity and safety and help healthcare facilities to confront these problems.

IT @ 2010 brings these cutting edge innovations into the global spotlight and gives them the recognition and media attention they deserve. Their stories will inspire others, proving that challenges can be transformed into future opportunities and success stories.

The IT @ Networking Awards are founded on the belief that healthcare professionals, the daily users of IT solutions, are best placed to judge the value of new projects. Our unique peer to peer voting system empowers the attending healthcare professionals to vote for their preferred projects alongside the panel of expert judges.

Out of all submissions, only the 25 best solutions will qualify to become a Nominee. They will be invited to present in the first round MindByte session and will be awarded the prestigious IT @ 2010 Nominee Medal.

Each MindByte includes a five minute introductory presentation followed by a five minute lively Q&A. The qualifying audience will vote immediately after each presentation based on the following criteria:

1. The Importance of Technology
What technology was used and how it was integrated into the workplace?

2. Benefits
Has the project helped those it was designed to help?
Has the project changed how tasks are performed?
What new advantage(s) or opportunities does the project provide?

3. Originality
What makes the solution special?
Are there any original features?
Is it the first, the only, the best or the most effective application of its kind?
Is it an improvement on existing implementations?

4. Difficulty
What were the most important obstacles that had to be overcome?
Were there any technical or organisational problems?

5. Success
Has the project achieved or exceeded its goals?
How do you see the project's success affecting other applications, your facility or other organisations?
How quickly would the users accept this innovation?

6. Impact
What is your overall impression of the project?
Would you consider implementing this IT solution in your healthcare facility?

Only the nine top-rated Nominees will progress as Finalists into the next day WORKBENCH. This is a 30-minute in-depth presentation followed by a lively 15-minute Q&A discussion, providing the audience with a thorough understanding of the project.

The qualifying audience will vote immediately after each presentation to choose the winners. Finalists will be awarded the prestigious IT @ Networking Awards 2010 Finalist Medal.

The Prize
Out of the finalists, the top three IT solutions will be awarded a prize.

The winning project will receive:

  • the IT @ Networking Awards 2010 Trophy;
  • a cash prize of Euro 5,000, this is the world's highest remunerated healthcare IT award, and
  • media promotion in Europe's leading healthcare management media worth Euro 50,000.

The second project will receive:

  • the IT @ Networking Awards 2010 Trophy;
  • media promotion in Europe's leading healthcare management media worth Euro 25,000.

The third project will receive:

  • the IT @ Networking Awards 2010 Trophy.

Project Submission
All entries must already be implemented in at least one site and must be fully operable. All projects must be presented in accordance to the voting criteria.

Submission deadline is 25 June 2010.

All project submissions will be presented to the IT @ 2010 Review Committee. This Review Committee will decide the top 25 IT solutions that will become Nominees and will take part in the MindByte Session.

Secure your presence now and take advantage of early bird registration until 31 May 2010.

For further information and registration, please visit:

Most Popular Now

Amgen and Allergan's MVASI™ (bevacizumab-awwb) and…

Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a bio...

Compound found in red wine opens door for new trea…

Like to unwind with a glass of red wine after a stressful day? Don't give alcohol all the credit. New research has revealed that the plant compound resveratrol, which is ...

HIV vaccine nears clinical trial following new fin…

A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar p...

Mylan and Upjohn, a division of Pfizer, to combine…

HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced a definitive agreement to combine Mylan with Upjohn, Pfizer's o...

Leading oncologists and nutritionists pinpoint are…

An international collaborative led by Ludwig Cancer Research and Cancer Research UK has identified key areas that are central to uncovering the complex relationship betwe...

Closing the door: breaking new ground related to a…

In order to sustain fast growth, cancer cells need to take up nutrients at a faster rate than healthy cells. The human glutamine transporter ASCT2 allows the amino acid g...

FDA approves first generics of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associat...

Roche and Spark Therapeutics, Inc. announce extens…

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") announced that Roche has extended the offering period of its previously announced...

FDA approves first treatment for severe hypoglycem…

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that c...

Rye is healthy, thanks to an interplay of microbes

Eating rye comes with a variety of health benefits. A new study from the University of Eastern Finland now shows that both lactic acid bacteria and gut bacteria contribut...

GSK completes transaction with Pfizer to form new …

The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and Panadol and Pfizer's Advi...

Eating more plant-based foods may be linked to bet…

Eating mostly plant-based foods and fewer animal-based foods may be linked to better heart health and a lower risk of dying from a heart attack, stroke or other cardiovas...